"Designing Growth Strategies is in our DNA"

Osteoporosis Treatment Market Size, Share & Industry Analysis, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator (SERMs), RANK ligand (RANKL) Inhibitor, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Others), and Regional Forecast, 2019-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101034

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Pipeline Analysis
    2. Key Industry Developments such as Mergers, Acquisitions, and Collaborations
    3. New Product Launches
    4. Key Industry Trends
  5. Global Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Bisphosphonate
      2. Hormone Replacement Therapy
      3. Selective Estrogen Receptor Modulator (SERMs)
      4. RANK ligand (RANKL) Inhibitor
      5. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Bisphosphonate
      2. Hormone Replacement Therapy
      3. Selective Estrogen Receptor Modulator (SERMs)
      4. RANK ligand (RANKL) Inhibitor
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Bisphosphonate
      2. Hormone Replacement Therapy
      3. Selective Estrogen Receptor Modulator (SERMs)
      4. RANK ligand (RANKL) Inhibitor
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Bisphosphonate
      2. Hormone Replacement Therapy
      3. Selective Estrogen Receptor Modulator (SERMs)
      4. RANK ligand (RANKL) Inhibitor
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Bisphosphonate
      2. Hormone Replacement Therapy
      3. Selective Estrogen Receptor Modulator (SERMs)
      4. RANK ligand (RANKL) Inhibitor
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Bisphosphonate
      2. Hormone Replacement Therapy
      3. Selective Estrogen Receptor Modulator (SERMs)
      4. RANK ligand (RANKL) Inhibitor
      5. Others
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2017)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. AbbVie Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Eli Lilly and Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Amgen Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Sanofi
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Pfizer Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Merck & Co., Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. GlaxoSmithKline plc
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Osteoporosis Treatment Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018 & 2026

Figure 3:  Global Osteoporosis Treatment Market Forecast (US$ Mn), by Bisphosphonate, 2015-2026

Figure 4:  Global Osteoporosis Treatment Market Forecast (US$ Mn), by Hormone Replacement Therapy, 2015-2026

Figure 5:  Global Osteoporosis Treatment Market Forecast (US$ Mn), by Selective Estrogen Receptor Modulator (SERMs), 2015-2026

Figure 6:  Global Osteoporosis Treatment Market Forecast (US$ Mn), by RANK ligand (RANKL) Inhibitor, 2015-2026

Figure 7:  Global Osteoporosis Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 8:  Global Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018 & 2026

Figure 9:  Global Osteoporosis Treatment Market Forecast (US$ Mn), by Oral, 2015-2026

Figure 10:  Global Osteoporosis Treatment Market Forecast (US$ Mn), by Parenteral, 2015-2026

Figure 11:  Global Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 12:  Global Osteoporosis Treatment Market Forecast (US$ Mn), by Hospitals Pharmacies, 2015-2026

Figure 13:  Global Osteoporosis Treatment Market Forecast (US$ Mn), by Retail Pharmacies & Stores, 2015-2026

Figure 14:  Global Osteoporosis Treatment Market Forecast (US$ Mn), by Online Pharmacies, 2015-2026

Figure 15:  Global Osteoporosis Treatment Market Value (US$ Mn), by Region, 2018 & 2026

Figure 16:  North America Osteoporosis Treatment Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 17:  North America Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018

Figure 18:  North America Osteoporosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 19:  North America Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 20:  North America Osteoporosis Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 21:  North America Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 22:  North America Osteoporosis Treatment Market Value (US$ Mn), By Country, 2018 & 2026

Figure 23:  North America Osteoporosis Treatment Market Value Share (%), By Country, 2018

Figure 24:  Europe Osteoporosis Treatment Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 25:  Europe Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018

Figure 26:  Europe Osteoporosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 27:  Europe Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 28:  Europe Osteoporosis Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 29:  Europe Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 30:  Europe Osteoporosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 31:  Europe Osteoporosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 32:  Asia Pacific Osteoporosis Treatment Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 33:  Asia Pacific Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018

Figure 34:  Asia Pacific Osteoporosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 35:  Asia Pacific Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 36:  Asia Pacific Osteoporosis Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 37:  Asia Pacific Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 38:  Asia Pacific Osteoporosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 39:  Asia Pacific Osteoporosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 40:  Latin America Osteoporosis Treatment Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 41:  Latin America Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018

Figure 42:  Latin America Osteoporosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 43:  Latin America Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 44:  Latin America Osteoporosis Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 45:  Latin America Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 46:  Latin America Osteoporosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 47:  Latin America Osteoporosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 48:  Middle East & Africa Osteoporosis Treatment Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 49:  Middle East & Africa Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018

Figure 50:  Middle East & Africa Osteoporosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 51:  Middle East & Africa Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 52:  Middle East & Africa Osteoporosis Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 53:  Middle East & Africa Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 54:  Middle East & Africa Osteoporosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 55:  Middle East & Africa Osteoporosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 56:  Global Osteoporosis Treatment Market Share (%), By Company, 2018

Table 1:  Global Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015–2026

Table 2:  Global Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015–2026

Table 3:  Global Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4:  Global Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5:  North America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 6:  North America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 7:  North America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8:  North America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9:  Europe Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 10:  Europe Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 11:  Europe Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Europe Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 14:  Asia Pacific Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 15:  Asia Pacific Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16:  Asia Pacific Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Latin America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 18:  Latin America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 19:  Latin America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Latin America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Middle East & Africa Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 22:  Middle East & Africa Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 23:  Middle East & Africa Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 24:  Middle East & Africa Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Osteoporosis Treatment Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase